Premium
Asenapine reduces manic and depressive episodes in maintenance trial for bipolar disorder
Publication year - 2018
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30284
Subject(s) - asenapine , bipolar disorder , bipolar i disorder , psychiatry , mood , medicine , depressive symptoms , treatment of bipolar disorder , placebo , atypical antipsychotic , schizophrenia (object oriented programming) , antipsychotic , psychology , mania , anxiety , alternative medicine , pathology
The atypical antipsychotic asenapine extended the time to recurrence of any mood episode when compared with placebo in a 26‐week maintenance trial for patients with bipolar disorder, researchers have reported. The results are significant in that many treatments used for bipolar disorder appear to be more effective in controlling manic or depressive symptoms but not both. Study results were published online Sept. 26 in the American Journal of Psychiatry .